Annalisa Verrico

Statistics

Publications

Citations

180

H-Index

Active since

2015

Affiliations

Institute of Molecular Biology and Pathology(Current)

Sapienza University of Rome

Istituto Pasteur

National Research Council

Frederick National Laboratory for Cancer Research

Annalisa Verrico is an author at Institute of Molecular Biology and Pathology specializing in molecular oncology, tubulin polymerization inhibitors, and cancer pharmacology.

ORCID

Publications per year

2015–2023

Publications

New Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent Cancer

Giuseppe La Regina, Ruoli Bai, Antonio Coluccia et al. · Journal of Medicinal Chemistry · 2015 · 58 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors

Giuseppe La Regina, Ruoli Bai, Antonio Coluccia et al. · European Journal of Medicinal Chemistry · 2018 · 39 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Mitotic cell death induction by targeting the mitotic spindle with tubulin-inhibitory indole derivative molecules

Erica Di Cesare, Annalisa Verrico, Andrea Miele et al. · Oncotarget · 2017 · 24 citations · Full text

Medicine, Oncology, Pharmacology +17

Visualization of human karyopherin beta-1/importin beta-1 interactions with protein partners in mitotic cells by co-immunoprecipitation and proximity ligation assays

Laura Di Francesco, Annalisa Verrico, Italia Anna Asteriti et al. · Scientific Reports · 2018 · 21 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13

Importin-β and CRM1 control a RANBP2 spatiotemporal switch essential for mitotic kinetochore function

Eugenia Gilistro, Valeria de Turris, Michela Damizia et al. · Journal of Cell Science · 2017 · 18 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

1–5 of 7